Back to Ingredient Dictionary

Common Name(s): Oleocanthal,extra virgin olive oil secoiridoid,natural ibuprofen-like anti-inflammatory

CAS Number: N/a

DESCRIPTION

What It Does: Oleocanthal reduces skin inflammation through direct cox-1 and cox-2 inhibition with potency equivalent to ibuprofen per molar concentration โ€” lowering prostaglandin e2 (pge2) production in inflamed skin, reducing erythema and inflammatory cascades in sensitive, reactive, or acne-prone skin, and providing antioxidant protection from the secoiridoid phenol's radical scavenging activity.

Why It's Used: Formulators choose oleocanthal for premium anti-inflammatory skin care formulations where the 'food-grade, extra virgin olive oil active' positioning provides a uniquely compelling natural anti-inflammatory narrative supported by unusually strong pharmaceutical evidence. unlike most natural anti-inflammatory claims that rely on general antioxidant activity, oleocanthal has a defined pharmaceutical target (cox inhibition), an identified mechanism (acylation of cox's active site serine), and direct comparison to an approved pharmaceutical (ibuprofen) demonstrating equivalent potency โ€” evidence quality that is exceptional for a botanical cosmetic active.

How It Works: Oleocanthal works through a pharmacological mechanism identical to non-steroidal anti-inflammatory drugs (nsaids) like ibuprofen: (1) cox inhibition โ€” oleocanthal's aldehyde group forms a covalent schiff base with lysine 353 at the entrance of cyclooxygenase (cox-1 and cox-2) active site channels. this covalent modification blocks arachidonic acid's access to the cox active site, preventing its oxidation to prostaglandin g2 (pgg2) โ€” the first step of the prostaglandin synthesis pathway. ic50 for cox-1 inhibition ~0.3 ฮผm, cox-2 ~0.6 ฮผm (ibuprofen cox-1 ic50 ~0.5 ฮผm, cox-2 ~0.7 ฮผm โ€” essentially identical potency per mole). reduced pgg2 โ†’ pgh2 โ†’ pge2 production means reduced prostaglandin-mediated vasodilation, pain sensitisation, and inflammatory cell recruitment; (2) direct antioxidant โ€” the dihydroxyphenol system provides radical scavenging through the catechol electron donation mechanism, providing antioxidant protection in addition to the cox inhibition anti-inflammatory activity; (3) anti-cancer potential โ€” oleocanthal disrupts cancer cell lysosomal integrity through a recently identified lysosomal cell death (lcd) pathway, increasing interest in its potential role in photocarcinogenesis prevention.

Typically Found In: Premium anti-inflammatory skin care,evoo-derived actives

TECHNICAL DETAILS

Primary Category: Active ingredient โ€“ antioxidant

Secondary Functions: Free radical scavenging,anti-aging

Application Areas:

Facial Skincare

Body Care

Hair Care

Beard Care

Color Cosmetics (Makeup)

Dietary/Oral Supplements

Typical Concentration Range: 0.05%โ€“1%

SOURCING & ETHICS

Vegan Status: Yes

Halal Status: Yes

Source Notes: Plant-derived extract or synthetic.

SKIN COMPATIBILITY

Irritancy Rating: 1/5 โ€“ very low

Comedogenicity Rating: 0/5 โ€“ non-comedogenic

Sensitivity Concerns: Non-irritating; well-tolerated.

Safe for Sensitive Skin: Yes

SAFETY & COMPATIBILITY

Safety Profile: Excellent safety profile. ewg score: 1.

Works Well With: Vitamin c,vitamin e,ferulic acid,spf,other antioxidants

Avoid Combining With: No significant incompatibilities

SCIENTIFIC NOTE

Oleocanthal ibuprofen equivalence discovery: chemical biologist paul breslin noticed evoo throat-burn was identical to throat-burn from ibuprofen ingestion. he confirmed oleocanthal and ibuprofen activate the same trpa1 sensory receptor in the throat and inhibit cox-1/cox-2 by the same mechanism at similar ic50 values. a typical 50 ml serving of premium evoo (~9 mg oleocanthal) provides the anti-inflammatory equivalent of ~10% of the analgesic dose of ibuprofen โ€” 'daily dose' anti-inflammatory activity from the mediterranean diet's olive oil consumption. this pharmacological equivalence between a food component and an approved analgesic drug is unique in food science.

Last Verified: 2026-03-12

Primary Sources: Annals of internal medicine 2005,oleocanthal cox inhibition ibuprofen review